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Abstract: Obesity prevalence is rapidly increasing worldwide. With the discovery of brown adipose
tissue (BAT) in adult humans, BAT activation has emerged as a potential strategy for increasing
energy expenditure. Recently, the presence of a third type of fat, referred to as beige or brite (brown in
white), has been recognized to be present in certain kinds of white adipose tissue (WAT) depots. It has
been suggested that WAT can undergo the process of browning in response to stimuli that induce
and enhance the expression of thermogenesis: a metabolic feature typically associated with BAT.
MicroRNAs (miRNAs) are small transcriptional regulators that control gene expression in a variety of
tissues, including WAT and BAT. Likewise, it was shown that several food compounds could influence
miRNAs associated with browning, thus, potentially contributing to the management of excessive
adipose tissue accumulation (obesity) through specific nutritional and dietetic approaches. Therefore,
this has created significant excitement towards the development of a promising dietary strategy
to promote browning/beiging in WAT to potentially contribute to combat the growing epidemic of
obesity. For this reason, we summarize the current knowledge about miRNAs and food compounds
that could be applied in promoting adipose browning, as well as the cellular mechanisms involved.
Keywords: miRNAs; browning; BAT; WAT; food compounds
1. Brown and Beige Adipose Tissue in Energy Balance
BAT is a type of adipose tissue characterized by multilocular lipid droplets, the abundance of
mitochondria, and a high rate of fatty acid oxidation and glucose uptake. It secretes batokines and
exhibits endocrine, paracrine, and autocrine actions. In addition, it plays an important role in energy
expenditure and non-shivering thermogenesis and is considered to have potential implications for the
treatment of obesity [1].
Moreover, brown adipocyte-like cells, beige or brite adipocytes, are a specialized cell type
derived from white-adipocyte precursor cells that display thermogenic capacity [2]. Functionally,
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brite adipocytes have the ability to efficiently oxidize glucose and lipids [3] to produce heat under
certain stimuli [4] (see Figure 1 and below). Further, providing their thermogenic capacity, stimulation
of these brite adipocytes (widely known as beiging or browning) has eventually been considered
as an interesting strategy against excessive energy accumulation observed in obesity [5]. From a
morphological point of view, brite adipocytes appear within white adipose tissue depots (mainly in
the subcutaneous depot), have multilocular smaller lipid droplets (as compared to white adipocytes),
display medium mitochondrial density, and express (inducible) uncoupling protein-1 (Ucp-1) [2].
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interaction/combination between environmental and transcriptional factors, including epigenetic 
mechanisms such as miRNAs [7] and dietary bioactive compounds such as polyphenols [8]. 
As explained in Figure 1, multiple factors have been related to browning activation in WAT [4], 
a negative energy balance being a common trait to many of them. Among the most relevant ones, this 
includes physical exercise, cold, stress hormones (noradrenaline and glucocorticoids), caloric 
restriction, and intermittent fasting. In this context, it has been speculated whether, in some cases, 
WAT browning is a negative adverse side effect given that it has been observed in severe-wasting 
situations such as burn-injured individuals, cancer-associated cachexia, or pheochromocytoma [9]. 
However, in general, the browning process is considered a promising strategy to revert the positive 
energy balance typical of obesity, and many studies have been devoted in the last years to study 
hormones, miRNAs, and physiological stimuli (i.e., physical activity and social stimulation) that are 
able to activate browning, including also dietary compounds that are involved in trans-differentiation 
from white to beige adipocytes. 
  
Figure 1. Most relevant nvironmental, behavioral, and physiological factors that regulate white adipose
tissue (WAT) browning. miRNAs, micro s; FGF21, Fibroblast growth factor 21; ANP, atrial natriuretic
peptide; BNP, brain-type natriuretic peptide; PPAR-γ, Peroxisome proliferator-activated receptor gamma.
The myogenic factor 5 (Myf5) give rise to brown adipocytes and also a subset of white
adipocytes. Individual brown and white adipocytes contain a mixture of adipocyte progenitor
cells derived fro f5+ and Myf5neg lineages, which varies depending n the depot location [6].
Thus, adip e evelopment towards a more white/brit phenoty e epends n a complex
interaction/combination between environmental and transcriptional factors, including epigenetic
mechanisms such as miRNAs [7] and dietary bioactive compounds such as polyphenols [8].
As explained in Figure 1, multiple factors have been related to browning activation in WAT [4],
a negative energy balance being a common trait to many of them. Among the most relevant ones,
this includes physical exercise, cold, stress h rmones (noradrenalin and glucocorticoids), caloric
restriction, and i termittent fasting. In this context, it h s been speculated wheth r, in ome cases,
WAT browning is a negative adverse side effect given that it has been observed in severe-wasting
situations such as burn-injured individuals, cancer-associated cachexia, or pheochromocytoma [9].
However, in general, the browning process is considered a promising strategy to revert the positive
energy balance typical of obesity, and many studies have been devoted in the last years to study
hormones, miRNAs, and physiological stimuli (i.e., physical activity and social stimulation) that are
able to activate browning, including also dietary compounds that are involved in trans-differentiation
from white to beige adipocytes.
2. MicroRNAs as Regulators of Gene Function and Metabolism
MiRNAs are non-coding ribonucleotid acid (RNA) molecules that regulate gene expression.
To clarify, MiRNAs are short, approximately 20 to 22 nucleotides in length, double stranded RNAs
that usually down-regulate gene expression at the post-transcriptional level [10]. For the last decade,
many hundreds of miRNAs have been identified with highly conservative sequences between species.
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Moreover, this high conservation degree shows important roles of miRNAs in the regulation of tissue
development, phenotype, and cell physiology [11], including adipose tissue [12–14].
In most cases, miRNAs repress gene transcription through specific and direct interaction of miRNA
and mRNA. This miRNA–mRNA interaction is based on base pair complementarity, and usually,
miRNAs interact with target mRNAs at their 3′UTR region [10,11]. However, other non-canonical
regions for miRNA interaction have also been described, such as the coding region or the 5′UTR [15].
The canonical miRNA mechanism of action involves a perfect base pair complementarity within the
“seed” sequence, framed within base pairs 2–8 of the mature miRNA strand, with the target mRNAs
sequence. Additionally, some mismatches could be present within the non-seed sequence of the
miRNA strand for the regulation of gene transcription. Indeed, one single miRNA can regulate many
mRNAs, and at the same time, one mRNA could be regulated by several miRNAs and, thus, affect
different cell functions [10,11,16–18]. Even so, this suggests that miRNAs constitute a wide and open
system for transcriptional regulation of gene expression in mammals. The biological impact of gene
transcription regulation through miRNAs demonstrates the plasticity of this system to finely tune gene
expression under environmental changes.
3. Involvement of miRNAs in the Regulation of Browning: Role of Nutritional Factors
In recent years, many studies have demonstrated the involvement of miRNAs in the regulation of
adipose tissue function and adipose tissue formation (adipogenesis) [12,13,19]. Of particular relevance,
miRNAs regulating brite adipocyte development and function have been a topic of interest for obesity
research [20]. Therefore, identification of specific miRNAs regulating brite/brown adipocyte function
could be envisaged as a potential therapeutic tool to improve the excess of WAT associated to obesity
and to stimulate energy dissipation as heat [21]. The role of miRNAs in the modulation of browning
relies on their ability to tiny regulate gene transcription, while some miRNAs have been found to be
positive regulators of brite/brown adipocytes (activators), others have shown to be potent inhibitors
of adipocyte browning [22,23]. Figure 2 displays some of the miRNAs found to regulate brite/brown
function that are briefly described in this review.
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Figure 2. MicroRNAs involved in WAT browni g an i e and brown adipocyte regulation. ↑,
upregulated; ↓, downregulated.
Importantly, several studies have also shown that nutritional and dietary factors could influence
miRNAs associated with browning, thus, potentially contributing to the treatment of excessive adipose
tissue accumulation (obesity) through specific nutritional and dietetic approaches. Tables 1 and 2
illustrate the most important nutritional factors that regulate browning as well as brown and brite
adipocyte-related miRNAs, respectively, as observed in human samples and cells. Table 3 shows
additional information about these miRNAs in animal and murine cell models.
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Table 1. Main miRNAs involved in brown adipocyte regulation and nutritional factors that regulate their expression in human samples/cells.
Effect on Browning miRNA Model and/or Tissue Sample Nutritional Factors Effect of the Nutritional Factor on the Expression of the miRNA Reference
Positive (+)
203 Human colon adenocarcinoma cells (Caco-2) Selenium (depletion/accurate levels) ↓miR-203 expression in Se depletion [24]
193b Human plasma Weight loss dietary treatment (RESMENA trial) ↑miR-193b levels (and hypomethylated) in high responders toweight loss [25]
365 Human adipocytes Obesity/adipose (WAT) hypertrophy ↑miR-365 in WAT hypertrophy [26]
Negative (−)
106b Lung cancer cells Seed procyanidin extract (GSE) cells ↓miR-106b in lung neoplastic cells [27]
LT97 cells (colon adenoma cells) Butyrate (and trichostatin A) as histonedeacetylase inhibitors
↓miR-106b levels: affects cycle-relevant genes and thus, cell
proliferation [28]
Plasma Hyperlipidemia status/coronary artery disease(CAD)
↓miR-106b in patients with CAD.
MiR-106b levels positively correlate with HDL-c & ApoA-I [29]
Human colon adenocarcinoma cells (Caco-2) Selenium (depletion/accurate levels) ↓miR-106b expression in Se depletion [24]
HCT116 (colon cancer cells) Butyrate (short chain FA) ↓miR-106b expression [30]
Prostate cancer cells Resveratrol treatment ↓miR-106b expression [31]
93
Human hepatocellular carcinoma (HCC) Nonalcoholic fatty liver disease (NAFLD) ↑miR-93 expression [32]
Human colon adenocarcinoma cells (Caco-2) Low-selenium environment ↓miR-93 expression levels in low selenium [33]
122 Exosomes from healthy males aged 20–30 y.o. Fat mass/BAT activity
↓ Exosomal miR-122-5p levels in high BAT activity group.
Exosomal miR-12anti-obesityp correlates negatively with: BAT
activity, serum HDL-cholesterol.
Exosomal miR-122-5p correlates positively with: age, BMI, body fat
mass, total cholesterol, and serum triglycerides.
[34]
Plasma Type 2 diabetes with/without NAFLD ↑miR-122 expression in T2DM patients with NAFLD as compared tothose without NAFLD [35]
Serum Breast cancer patients (survivors) with differentBMI ranges (obesity, weight gain) miR-122 expression associated with BMI [36]
Liver samples Patients with alcoholic liver diseases (ALD) miR-122 levels ↓ in liver samples from ALD patients↑ levels of miR-122 target HIF1-α [37]
Liver samples Obese women following bariatric surgery with orwithout NAFLD
↓miR-122 in obese subjects with NAFLD
↓miR-122 in liver associated with impaired FA usage [38]
Plasma Maternal (pre-gestational and gestational) obesity ↓miR-122 levels in pre-gestational obesity and gestational obesity [39]
Human liver cancer cells (HepG2) Flavonoid compounds (nobiletin, tangeretin, andhesperidin) from citrus peel
↓miR-122 expression and thus, affect FAS and CPT-1α, decreasing
lipid accumulation [40]
Serum and plasma Individuals with risk factors for metabolicsyndrome, T2D, CVD (Bruneck study)
Circulating miR-122 associated with ↑ levels of liver enzymes,
adiposity, inflammation, and insulin resistance and an adverse lipid
profile Circulating miR-122 levels correlated with lipid subspecies
(monounsaturated and saturated fatty acids) and cholesterol esters
[41]
↑, upregulated; ↓, downregulated.
Int. J. Mol. Sci. 2019, 20, 5998 5 of 32
Table 2. Main miRNAs involved in brite adipocyte regulation and WAT browning and nutritional factors that regulate their expression in human samples/cells.
Effect on Browning miRNA Tissue Sample Nutritional Factor Effect of the Nutritional Factor on the Expression of the miRNA Reference
Positive (+)
196a (specific) Pancreatic cancer cells Dietary phytochemicals (garcinol) Modulated miR-196a expression [42]
26a/b
Formalin-fixed paraffin-embedded lung cancer
(144 adenocarcinomas and 120 squamous cell
carcinomas)
Intake of quercetin-rich foods (evaluated through
a food-frequency questionnaire)
miR-26 expression differentially expressed between highest and
lowest quercetin consumers [43]
Liver (human) HFD/obesity ↓miR-26 expression [44]
32 Healthy human colorectal epithelium Non-digestible carbohydrates (resistant starch andpolydextrose) supplementation ↑miR-32 expression in rectal mucosa [45]
455 Human adipose tissue and blood cells Obesity & T2D (computational frameworkmiR-QTL-Scan) BAT specific miR-455 play a role in adipogenesis [46]
Human adipose tissue (BAT and WAT) from neck HFD/Obesity and cold-induced thermogenesis MiR-455 identified as a BAT marker in humans [47]
Negative (−)
125-5p (specific) Blood from T2DM and obese patients Meta-analysis including lifestyle interventionstudies ↓miR-125-5p in obese patients [48]
34a Human sc WAT (48 subjects)
Three calorie-restricted diets (different amount
and quality of carbohydrates): low glycemic index,
high glycemic index, and low fat
↓miR-34a in waist circumference stratified (tertiles) cohort
No changes on miRNA levels between the intervention groups. [49]
Liver of male Sprague-Dawley rats High-fat high-cholesterol (WD) diet supplementedwith fish oil (FOH) ↓miR-34a in FOH vs. WD [50]
Huh-7 (human liver) cells Cholesterol accumulation associated tononalcoholic fatty liver disease (NAFLD) ↑miR-34a expression in liver [51]
155 THP-1 (human) monocytes/macrophages Oleic acid ↑miR-155 expression in monocytes (vs. DHA) [52]
378 Patients with NASH (liver biopsies)Human HepG2 with accumulated lipid (oleate)
N.A.
Oleate
↑miR-378 expression
↑miR-378 expression [53,54]
Muscle biopsies of healthy males
Single bout of concurrent resistance exercise (8 × 5
leg extension, 80% 1RM) + 30 min at ~70%
VO2peak with either post-exercise (whey) protein
(25 g) or placebo
↑miR-378 expression at 4 h post-exercise with protein [55]
↑, upregulated; ↓, downregulated.
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Table 3. Main miRNAs involved in brown adipocyte regulation and nutritional factors that regulate their expression in animal and murine cell models.
Effect on browning miRNA Tissue sample Nutritional factor Effect of the nutritional factor on the expression of the miRNA Reference
Positive (+)
196a (specific) Adipose tissue (sc and visceral) of lambs
DHA-G diet: barley-based finishing diet where algae
meal (DHA-Gold; Schizochytrium spp.) replaced flax
oil
↑miR-196a expression in SAT vs. PAT (perirenal) in DHA-G diet.
Differential miRNA expression in each tissue depot depending on
diet
[56]
Bovine adipose tissue (sc and visceral)
from cattle HFD ↓miR-196a in HFD and higher expression in visceral tissue depot [57]
26a/b Goat milk Milk (fatty acid) composition
miR-26 expression associated with total fat yield and short-, medium
and long-chain fatty acid content.
No association with lactose or milk protein content.
Positive correlation miR-26a family and C16:1 and C18:3 in milk fat.
[58]
Liver and adipose tissue (pregnant) rats
Diets with different fatty acid types: soybean (SO),
olive (OO), fish (FO), linseed (LO), or palm-oil (PO)
diets from conception to day 12 of gestation and
standard diet thereafter
MiR-26 (among others) differentially modulated by the different fatty
acids during early pregnancy. [59]
Liver (human) & mice HFD/obesity ↓miR-26 expression (humans and two obesity mice models) [44]
30b/c Cortex and cerebellum of middle-agedC57Bl/6J mice
Extra-virgin olive oil rich in phenols feeding for 6
months (H-EVOO, phenol dose/day: 6 mg/kg) vs. the
same olive oil deprived of phenolics (L-EVOO)
↓miR-30 expression in H-EVOO
↑miRNAs in old L-EVOO animals compared to young. [60]
Rainbow trout eggs Trout egg quality and production (characterization ofmiRNA profile) miR-30 among top-10 most abundant miRNAs [61]
Mice adipose tissue macrophages
(ATMs)
HFD (12 wk) in combination with CB1 antagonist
AM251 (4 wk, 10 mg/kg) ↑miR-30e-5p in ATMs from HFD + AM251 mice [62]
Male C57BL/6J mice HFD (16 wk) ↓miR-30a, -30c, -30e expression in ATM from HFD mice vs. NCDthrough epigenetic (methylation) modifications [63]
455 Male C57BL/6J (B6) mice HFD (45% kcal fat) supplemented with EPA (6.75%kcal EPA) for 11 wk. ↑miR-455 expression in BAT [64]
Murine adipose tissue (BAT and WAT) HFD/Obesity and cold-induced thermogenesis MiR-455 identified as a BAT marker in rodents [47]
Negative (−)
27b Milk samples from rats (lactation) Cafeteria and post-cafeteria diet MiR-27 levels in milk decrease throughout lactation. [65]
Cortex and cerebellum of middle-aged
C57Bl/6J mice
Extra-virgin olive oil rich in phenols feeding for 6
months (H-EVOO, phenol dose/day: 6 mg/kg) vs. the
same olive oil deprived of phenolics (L-EVOO)
↓miR-27 levels in H-EVOO [60]
34a Breast cancer cells and carcinogenesismodel in rats 3,6-dihydroxyflavone (flavonoid) ↑miR-34a in breast carcinogenesis [66]
Liver of male Sprague-Dawley rats High-fat high-cholesterol (WD) diet supplementedwith fish oil (FOH) ↓miR-34a in FOH vs. WD [50]
Mice liver
Three dietary interventions affecting lifespan (LS):
caloric restriction (CR), low fat or high fat plus
voluntary exercise or 30% CR
↑miR-34a in livers of two models of obesity
MiR-34a fold change negatively correlated with LS [67]
Mouse pancreatic β-cells Saturated fatty acids ↑miR-34a expression [68,69]
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Table 3. Cont.
Effect on browning miRNA Tissue sample Nutritional factor Effect of the nutritional factor on the expression of the miRNA Reference
133 C57BL/6 male mice High fat diet concomitant with miR-133 ASO(anti-miR-133)
↑miR-133 expression in HFD
↓miR-133 expression in cold-exposed mice
HFD and miR-133 antagonism ↑ BAT activity
[70]
155 3T3-L1 (mouse) adipocytes Resveratrol (25 µM) ↑miR-155 expression [71]
FVB mice (colon mucosa) High fat diet (45%) and 30% caloric restriction (CR) ↑miR-155 expression in colon mucosa in HFD mice [72]
RAW264.7 macrophages (LPS activated) 10 µM quercetin, quercetin-3-glucuronide (Q3G) andisorhamnetin ↓miR-155 expression by quercetin and Q3G [73]
378 Livers of dietary obese mice HFD (60% cal.) ↑miR-378 expression [53,54]
Milk samples from dairy cows in mid
lactation
Control diet (total mixed ration of corn:grass silages)
for 28 days followed by a treatment period (control
diet supplemented with 5% linseed or saﬄower oil) of
28 days.
↑miR-378 expression by both treatments [74]
Mice livers
Mouse primary hepatocytes
Fasting & re-feed
Palmitic acid (PA), linoleic acid (LA), oleic acid (OA)
↑miR-378 expression in fasting & ↓miR-378 upon re-feeding
↑miR-378 expression [29]
Mice liver Fisetin (a flavonoid): normal diet, HFD, HFD + fisetin ↑miR-378 expression by HFD & ↓miR-378 by fisetin sup. [75]
Mice brown adipocytes
Brown fat (BAT) from mice
Omega-3 eicosapentaenoic acid (EPA)
Low fat diet (LF), iso-caloric high fat (HF, 50% cal.)
enriched with palm oil (HF + PO), olive oil (HF + OO),
fish oil (HF + FO) for 12 wk.
↑miR-378 expression by EPA during brown differentiation
↑miR-378 expression in iBAT from mice treated with HF + FO vs.
HF + OO or HF + PO.
[76]
↑, upregulated; ↓, downregulated.
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4. Food Compounds Related to the Browning Process
Evidence has shown that some food compounds could be promising candidates to target different
molecular mechanisms and dietary strategies in the management of obesity, and, even more, some of
them have the potential ability to promote the browning process in WAT. For instance, some of the
most studied compounds are spices, green tea, polyunsaturated fatty acids (PUFA´s), carotenoids, and
citrus fruits, among others.
4.1. Spices
4.1.1. Chili Peppers
Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is a bioactive component of chili peppers [77,78],
and is also the major pungent component of red-hot chili peppers. Additionally, chili
peppers contain non-pungent capsinoids analogs, which include: capsiate, dihydrocapsiate, and
nordihydrocapsiate [78,79]. It is widely accepted that capsaicin and capsinoids activate BAT and
increase thermogenesis, as well as energy expenditure in both rodents and humans [79–82]. In addition,
there is increasing evidence regarding the browning effect of capsaicin and capsinoids.
Baboota et al. [83] reported that male Swiss albino mice fed a high-fat diet (HFD) receiving 2
mg/kg body weight of capsaicin (orally administered on alternate days; capsaicin was dissolved in 0.9%
saline with 3% ethanol and 10% Tween 80) for 12 weeks had an induction of the browning phenotype
in subcutaneous WAT, but not in the visceral WAT, and showed increased on thermogenesis and
mitochondrial biogenesis genes expression in BAT.
Baboota et al. [84] also showed that 3T3-L1 adipocytes treated with 1 µM of capsaicin increased
the expression of Ucp-1, Pgc-1α, Prmd16, Dio2, Pparα, and Foxc2, not only suggesting that capsaicin
induced a brown-like phenotype but that this effect was via the transient receptor potential vanilloid
subfamily 1 (TRPV1)-dependent mechanism.
Baskaran et al. [85] confirmed in mice that the activation of TRPV1 channels by capsaicin triggers
browning of WAT. Adult male TRPV1-/- mice were fed an HFD with added capsaicin (0.01%) from
week 6 to week 32. Dietary capsaicin increased the expression of Ucp-1, Pgc-1α, Sirt-1, and Prdm16 in
WAT wild type mice. Hence, capsaicin had no effect on the expression of these genes in TRPV1-/- mice.
Thus, TRPV1 protein may have a central role in capsaicin-mediated browning of WAT.
Mosqueda et al. [86] described that adult male Wistar rats that were fed a Western diet for eight
weeks and treated daily with capsaicin (4 mg/kg/day) induced in retroperitoneal WAT the emergence of
multilocular brown-like adipocytes that were positive for UCP-1 and CIDEA. In addition, the increased
expression of Prdm16 was observed in the inguinal WAT of these animals.
Fan et al. [87] reported that mature 3T3-L1 adipocytes were tested with a combination of capsaicin
(25 µM) and capsiate (25 µM) for 48 h increased the expression of Tbx1, Tmem26, Cd40, Ucp-1, and
Prdm16, in 3T3-L1 adipocytes and also increased the protein levels of UCP-1, PGC-1α, and PRMD16.
The induction of browning in white adipocytes by a combination of capsaicin and capsiate could be
mediated via activation of the peroxisome proliferator-activated receptor gamma/beta3 adrenoreceptors
(PPARγ/β3-AR) signaling pathway.
Ohyama et al. [88] described a synergistic anti-obesity effect by a combination of capsinoids and
mild cold exposure promoting beige adipocyte biogenesis. Adult male C57BL/6J mice were fed a
high-fat diet with 0.3% (w/w) of capsinoids (62.7% of capsiate, 32.2% of dihydrocapsiate, and 5.5%
nordihydrocapsiate) for eight weeks. Due to a mild cold exposure, 17% of these animals had increased
expression of Ucp-1, Pgc-1α, and Cidea, in the inguinal WAT when compared with vehicle-treated
mice and mice kept under room temperature. Cells treated with nonivamide (the less pungent
capsaicin-analog), decreased the adipogenesis process through an increase in the expression of the
miRNA mmu-let7d-5p, which has been associated with decreased PPARg levels [89].
Int. J. Mol. Sci. 2019, 20, 5998 9 of 32
4.1.2. Turmeric
Curcumin is a polyphenol isolated from the rhizomes of the plant Curcuma longa, commonly
known as turmeric, a member of the ginger family (Zingiberaceae). It is widely used as a spice in
Asian cuisine [90,91]. Curcumin is practically insoluble in water [92] and has poor absorption into
the gastrointestinal tract in rats, displaying a low oral bioavailability [93]. In vitro and animal studies
support the hypothesis that curcumin may promote thermogenesis and/or the browning process. For
instance, Wang et al. [94] reported that mice treated with curcumin (50 or 100 mg/kg/day) for 50 days
displayed a lower body weight gain and lower fat mass without any effect of food intake, and also
showed better tolerance to cold exposure. Particularly, in these animals, curcumin induced browning
of the WAT but in a depot-dependent manner, since increased mitochondrial biogenesis and increased
expression of Ucp-1 and other brown-fat specific genes were found in inguinal but no in epididymal
WAT (eWAT). In addition, these animals presented higher circulating levels of norepinephrine and
increased expression of the β3-AR in the inguinal WAT, suggesting that the browning of the inguinal
WAT (iWAT) is mediated by the norepinephrine-β3-AR pathway. Moreover, Nishikawa et al. [95]
also reported that the oral administration of curcumin formulations with higher bioavailability than
native curcumin increased browning in iWAT tissue of mice. Song et al. [96] reported that male
C57BL/6J mice fed with a high-fat diet plus 1% of curcumin presented higher thermogenic capacity in
response to a cold challenge, already evident after two weeks of treatment. In addition, a long-term
dietary intervention (17 weeks) did not affect iWAT browning but increased Ucp-1, Ppara, and Pmrd16
expression in the BAT. About miRNAs, there are no reports concerning the browning process; however,
it has been seen that curcumin markedly increased the content of miRNA-34a in SGC-7901 cells,
inhibited proliferation, migration, and invasion. As described above, miRNA-34a has been studied in
human WAT and expressed negatively with waist circumference [49,97].
In vitro studies have shown that curcumin also induces browning and mitochondrial biogenesis
in 3T3-L1 cell line and primary inguinal white adipocytes [98,99]. Curcumin significantly increased
several brown fat markers in both adipocytes in a dose-dependent manner (doses ranged from 1
to 20 µM). In fact, this effect seems to be mediated via the AMP-activated protein kinase (AMPK)
pathway [99]. In addition, a proteome analysis of primary inguinal white adipocytes treated with 20
µM curcumin for six to eight days revealed that curcumin increased protein levels related to fatty acid
oxidation, lipolysis, and browning-specific markers [98].
4.1.3. Thyme
Thymol (2-Isopropyl-5-methylphenol) is monoterpene phenol, and the major constituent of
essential oils isolated from plants belonging to the Lamiaceae family such as Thymus (Thymus
vulgaris) [100,101]. Thymus vulgaris is a native plant of Mediterranean regions traditionally used
as a culinary herb and also in traditional medicine [101]. Not to mention, it is also used in the food
industry for its flavoring and preservative properties [100]. Therefore, it has not been deeply studied
regarding its effect on body weight control, thermogenesis, or browning effect, and, in addition, there
is no evidence related to any miRNA. However, Choi et al. [102] described that thymol might promote
fat browning and lipid metabolism in 3T3-L1 adipocytes. Meanwhile, adipocytes treated with 20 µM
of thymol increased mRNA and protein levels of PGC-1α, PRMD16, and UCP-1. In addition, there
is a synergic increase of Fgf21, Pgc-1α, Prdm16, Tmem26, and Ucp-1 (brow fat-specific genes) in the
presence of 20 µM of thymol together with 50 nM triiodothyronine and 1 µM rosiglitazone (browning
cocktail). Overall, the authors suggest that thymol might promote the browning of white adipocytes
via activation of the β3-AR pathway.
4.1.4. Cinnamon
Cinnamon is produced from the bark of trees from the genus Cinnamomum and belongs to the
family Lauraceae [103]. The major components are cinnamaldehyde and cinnamic acid [104]. Regarding
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the bioactive compounds of cinnamon, recent studies showed biological effects of cinnamaldehyde, such
as anti-inflammatory, antioxidant, and anti-obesity properties [105]. Also, several hydroxycinnamic
acid derivatives, such as cinnamic acid, ameliorated the obesity induced by an HFD in rats [106].
Furthermore, trans-cinnamic acid (tCA), as an analog of cinnamon, demonstrated beneficial properties
on body weight and blood lipids in obese rats [104]. In this context, regarding the molecular
mechanisms of cinnamon and its bioactive compounds, several in vitro studies have been developed
on murine adipocytes and found that cinnamaldehyde (40 µM) prevents adipocyte differentiation
through the downregulation of Ppar-γ and Ccat-enhancer-binding protein alpha (C/EBPα) [107].
Regarding the browning process, Prdm16 interacts directly with Ppar-γ and plays an important role
in the thermogenesis process [108]. Thus, in an in vitro study, tCA induced browning in 3T3-L1
cells in a concentration of 200 µM upregulated protein expression of PGC-1α, PRDM16, and UCP-1
and upregulated genes involved in the browning process and beige-fat-specific like Pgc1-α, Prdm16,
and Ucp-1 [104]. Similarly, in an in vivo study, cinnamaldehyde supplementation (10 mg/kg BW)
downregulated adipogenic genes and promoted lipolysis and brown adipose tissue activity. These
results led to decreased body weight gain and fat accumulation after 14 weeks of treatment [107].
Likewise, another study showed that cinnamaldehyde supplementation (40 mg/kg/day) decreased
body weight by inducing the browning of WAT in HFD-fed mice [108]. However, although the effects
of cinnamon and its bioactive compounds on the browning process have been identified, to date,
the relationship with miRNAs has not been described. Not only was it not directly in an obesity
model, but a recently published article also showed that cinnamaldehyde regulates inflammation in
macrophages through the suppression of miR-21 and miR-155 [109]. Not to mention, the study focused
on inflammatory bowel disease and ulcerative colitis. As a result, a relationship has been found with
the suppression of miR-155 in the process of browning [110].
4.1.5. Garlic
Bioactive compounds from garlic (Allium sativum L.) have been studied for their possible
anti-obesity effect in in vitro models, animal models, and clinical trials [107]. The most abundant
biocompounds present in garlic are allicin, alliin, diallyl sulphide, diallyl disulphide, diallyl trisulfide,
ajoene, and S-allyl-cysteine [111]. In this context, some of these compounds have been shown to
exert effects on lipid accumulation, such as ajoene, in concentrations from 25 µM to 200 µM in
3T3-L1 cells [112]. Furthermore, other in vitro studies have been developed to investigate the effects
of garlic-derived organo-sulfur compounds. Thus, the results report a decrease in intracellular
triglycerides after diallyl trisulphide in adipocytes [107]. Additionally, the authors highlighted the
possible molecular mechanisms to decrease gene expression related to adipogenesis, as well as the
increase in genes related to fatty acid oxidation, such as Ucp-1 [107]. Also, in relation to garlic
biocompounds and its anti-obesity properties, it has been identified that thiacremonone enhanced the
mRNA level of uncoupling protein-2 (Ucp-2) in 3T·-L1 cells [113]. Similar results have been found in
in vivo studies, suggesting an anti-obesity effect of garlic supplementation. In this regard, M. Kim and
Kim demonstrated a potential anti-obesity effect of garlic (2% or 4%) in obese mice, downregulating
adipogenic genes. Likewise, in another study with obese mice treated with garlic powder (2% or 5%)
for seven weeks, lower body weight, WAT, and adipogenic gene expression was found in WAT and
increased Ucps mRNA levels and AMPK activity in BAT [114]. All these studies have demonstrated the
effect of garlic and its biocompounds on the browning process in different in vitro and in vivo models.
However, although the modulation of miRNAs by garlic has been identified, its effects have not been
related, so far, with the browning process. More studies are needed to highlight the effect of garlic and
its biocompounds on miRNAs and BAT.
4.1.6. Onion
Quercetin is one of the most abundant flavonoids present in food (onions, apples, tea, and red
wine) [115] and is the aglycone form of other glycosidic flavonoids. In this context, as an example, onion
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(Allium cepa L.) is a natural source rich in phenolic compounds, fructans, and organosulfur compounds.
Phenolic compounds from onion, especially flavonols such as quercetin, are secondary metabolites
that have been widely studied for the anti-obesity effects [116]. Possible anti-obesity mechanisms of
quercetin could involve AMPK and mitogen-activated protein kinase (MAPK) signaling pathways.
AMPK is a key regulator of energy balance inducing mitochondrial biogenesis and, therefore, promoting
BAT. In this context, Lee et al. [117] showed increased expression of genes related with brown adipocyte
development, such as Prmd16, Ucp-1, and Pgc1-α in retroperitoneal white adipose tissue (rWAT) of
mice fed with HFD supplemented with 0.5% onion peel extract (OPE) for eight weeks. In addition, the
same authors demonstrated the conversion of white to brown adipocytes in 3T3-L1 cells cultivated
with 50 µM of quercetin during the differentiation process (6 days) [117]. Also, another in vivo study
found lower triglycerides levels in mice fed HFD supplemented with quercetin (0.1% w/w) for 12
weeks. This result may be mediated by the increased expression of Ucp-1 in sWAT [118]. Although the
role of miRNAs as a potential mechanism involved in the regulation of the browning process has not
been specially described, some miRNAs could be implicated in the inflammatory response [119]. In
a recent study, the effect of quercetin on miR-155 expression in RAW264.7 macrophages stimulated
with lipopolysaccharide (LPS) was evaluated. Thus, they demonstrated that treatment with quercetin
(10 µM) down-regulated the expression of miR-155 in LPS-stimulated macrophages [73]. Another
study showed that quercetin and isorhamnetin (a quercetin metabolite) improved the inflammatory
status induced by LPS in murine macrophages, and suggested miR-155 as a regulatory inflammatory
mediator [120]. Although, in these studies, miR-155 was related to the macrophage response to various
types of inflammatory markers. Likewise, other studies described that the inhibition of miR-155 could
enhance brown adipocyte differentiation through the browning process [110,121]. On the other hand,
a recent study identified an upregulated miR-369-3p expression level in dendritic cells treated with
quercetin. The foregoing led to the down-regulation of C/ebp-β, which resulted in a lower production
of inflammatory cytokines [122].
4.2. Other Herbal and Food Compounds
4.2.1. Magnolia Officinalis
Magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) is a hydroxylated biphenyl active compound
isolated from Magnolia officinalis [123,124]. In fact, a range of biological activities has been attributed to
magnolol, such as antiinflammation, antioxidation, antiangiogenesis, and anticancer activities [123,124].
In addition, it has been described that long-term supplementation of magnolol (17 mg/kg BW per
day for 16 weeks) ameliorates body fat accumulation, insulin resistance, and adipose inflammation in
HFD fed male C57BL/6J mice [125]. Moreover, regarding the thermogenic or browning effect in the
adipocytes, Parray et al. [126] described that 3T3-L1 adipocytes treated with 5–20 µM of magnolol
during differentiation displayed a dose-dependent increase in the protein level UCP-1, PGC-1α,
PRMD16, and PPARγ. The addition of 20 µM of magnolol in the presence of a 50 nM triiodothyronine
with 1 µM rosiglitazone from day six to eight of differentiation in 3T3-L1 cells increased the expression
of specific browning markers such as Ucp-1, Pgc-1α, Prmd16, Cd137, Tbx1, and Cidea. In sum, these
results suggest that magnolol might promote the browning of 3T3-L1 adipocytes. Also, magnolol
increases UCP-1, PGC-1α, and PRDM16 in HIB1B brown adipocytes.
Honokiol ((3′,5-di-(2-propenyl)-1,1′-biphenyl-2,2′-diol) is a phenylpropanoid molecule found in
several species belonging to the genus Magnolia [127,128]. Firstly, it presents a structural homology with
magnolol [129], and magnolol is a structural isomer of honokiol [124]. Secondly, among the different
effects attributed to honokiol, it has been suggested that it may promote neuroprotection [127,129]
and may exert an anticarcinogenic effect [130]. Furthermore, there is scarce literature on the effect of
honokiol on body weight control or its effect on thermogenesis, at least in vivo. Also, in vitro studies
on 3T3-L1 adipocytes pointed out an induction of brown adipocyte-like phenotype in white adipocytes
by honokiol. In addition, these cells presented a dose-dependent (1–20 µM) increase in the protein
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levels of PGC-1α, PRDM16, and UCP-1. Moreover, 3T3-L1 adipocytes grown on a media containing
20 µM of honokiol from day six to eight of differentiation presented increased mRNA levels of Cidea,
Cox8, Fgf21, Pgc-1α, and Ucp1 (genes characteristics of brown adipocytes) and increased protein levels
of C/EBPβ, PPARγ, and peroxisome proliferator-activated receptor delta (PPARδ) (key regulatory
proteins for browning). In fact, the authors suggest that the induction browning in these cells could be
mediated through the activation of extracellular signal-regulated kinase (ERK).
Likewise, honokiol also increased the levels of PGC-1α, PPARγ, PRDM16, and UCP-1 in HIB1B
cells (at 20 µM) (when these cells are fully differentiated, they express Ucp RNA like BAT in vivo;
thus, these are good cell models for studying the regulation of Ucp gene expression in BAT and
metabolism [131,132]. Nowadays, it is known that the magnolol induces miR-200c expression in breast
cancer cells [133], with regard to this, miR-200c is also related to the browning process in humans [121].
4.2.2. Berberine
Berberine is an isoquinoline alkaloid derived from the Chinese medicinal plant Coptis chinensis
(Chinese goldthread) [134]. It has been found that berberine inhibits fat accumulation adipocytes
in vitro and in diet-induced obese mice and also can induce weight loss in rodents and human
subjects [135–139]. Henceforth, recent emerging evidence suggests that berberine increases energy
expenditure, thermogenesis, and browning.
Zhang et al. [140] reported that obese db/db mice treated for four weeks with berberine (i.p,
administration of 5 mg/kg/day) had higher rectal temperature and presented improved cold tolerance
than control animals. In fact, berberine administration also induced the expression of Pgc-1α, Ucp-1,
and Cidea, among others, in BAT of obese db/db mice. Also, berberine administration induces browning
of iWAT but not in eWAT. In iWAT, obese db/db mice treated with berberine presented increased
expression of Pgc-1α, Ucp-1, and Cidea. These animals also had increased mitochondrial biogenesis
and a BAT-like phenotype of inguinal adipocytes.
Lin et al. [141] showed that HFD-fed C57BL/6J mice treated with berberine at 100 mg/kg/day
in 0.9% saline by oral gavage had reduced obesity and were protected against the development of
hyperglycemia, hyperlipidemia, and insulin resistance. In addition, berberine treatment increased
oxygen consumption and the expression of Ucp-1 and tyrosine hydroxylase (rate-limiting enzyme
in the heat production process) [142]. The 3T3-L1 cells treated with 5 µM berberine for 48 h had
increased expression of CITED1, BMP7, PRDM16, and UCP-1. This effect may be mediated through
transcription-coupled post-transcriptional regulation. In another study, a treatment with berberine
revealed a decrease in miRNA-92a, which led to an increase in RNA-binding motif protein 4a (RBM4a)
expression, promoting the beige adipogenesis in 3T3-L1 [141].
Wu et al. [143] reported that in 10 overweight individuals with NAFLD that received berberine for
one month (0.5 g, 30 min before eating, three times a day), there was an increase in the mass and activity
of BAT. In addition, HFD-induced obese mice that received berberine for six weeks (i.p, administration
of 1.5 mg/kg/day) displayed enhanced BAT thermogenesis and reduced body weight gain. Therefore,
these animals presented higher rectal temperature and increased expression of Ucp-1, Prdm16, Pgc-1α,
Ppargc1b, and Elovl3, and higher protein levels of UCP-1 and PRDM16 in BAT compared to their
controls. However, berberine administration did not induce the typical browning phenotype in iWAT
or eWAT.
4.2.3. Panax ginseng
Panax ginseng is one of the most used traditional Chinese herbs and has an approximately
2500-year medicinal history in Eastern Asia, and is a slow-growing perennial plant that belongs to
the genus Panax in the Araliaceae family [144]. The majority of P. ginseng contains protopanaxadiols
and protopanaxatriols as dammarane type triterpene saponins [145]. Among them, ginsenoside
Rb1 is the main protopanaxadiol saponin, and ginsenoside Re, Rg1, and notoginsenoside R1 are
the main representative protopanaxatriol components [146]. The importance of ginseng lies in its
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multiple pharmacological functions, such as anticancer activity, as well as antioxidant and aging
inhibitory effects [77]. Additionally, fat accumulation in obesity involves two cellular mechanisms:
WAT hypertrophy and hyperplasia [147]; likewise, there are several reports showing that ginseng can
reduce adipocyte size and fat storage in mice and rats fed with HFD [148]. Therefore, an effect of Rg1
has been demonstrated to suppress the accumulation of triglycerides (TG) in 3T3-L1 cells and the
obesity model induced by the HFD of zebrafish [149].
AMPK, a critical regulator of energy metabolism, has been shown to play a key role in adipose
tissue metabolism [150]. In fact, AMPKα1 activation has been found to be involved in the regulation of
browning in iWAT of mice [151]. As a result, it has been shown that Rg1 induces BAT-like differentiation
of adipocytes and thermogenic activation, which is a process that also involves the upregulation of
fatty acid oxidation through the activation of AMPK. Consequently, lipid droplets take a form typical
of brown adipocytes and Ucp-1 expression is induced, and mitochondrial activity increases [152]. In
this sense, a study revealed that Rb2 activates BAT and induces browning of WAT, which increases
energy expenditure and thermogenesis and consequently ameliorates obesity and metabolic disorders,
suggesting Rb2 to be a promising beneficial compound treating obesity [153]. In diet-induced obese
mice supplemented with Rb2 BAT activation and WAT browning, as shown by reducing lipid droplets,
increasing Ucp-1 staining, and activating brown gene programs [154]. Thereupon, miR-27b is identified
to regulate adipogenesis by targeting Ppar-γ2, and in this sense, has shown that expression levels for
both of miR-27b and its primary transcript, pri-mir-27b, were found to decrease upon ginsenoside Rb1
treatment in 3T3-L1, which in turn promotes Ppar-γ expression and adipogenesis [155].
4.2.4. Mentha
The commercially important species Mentha piperita and M. arvensis are cultivated for the essential
oil used in food, confection, cosmetics, alcoholic beverage, tobacco, and pharmaceutical industries [156].
The essential oil of members of the mint (Lamiaceae) family is dominated by monoterpenes. In fact,
menthol is one of the major constituents of essential oil of both species. Despite the similarity in the
menthol biosynthetic pathway of these two species, the compositional variations in the essential oil
cannot be ignored, as M. arvensis essential oil constitutes the major trading essential oil for menthol in
the world. Likewise, menthol is a chemical cooling agent naturally produced from mint oils or prepared
synthetically [157]. Consequently, a cold sensation in mammals is detected by several cold-sensors;
among them, the most preeminent one is the cold and menthol receptor, canonical transient receptor
potential cation channel subfamily M member 8 (TRPM8) [158]. Some findings highlight the role of
menthol-induced TRPM8 activation in Ucp-1 dependent thermogenesis and energy expenditure [159].
Activation of TRPM8 receptors in the gut and skin by oral and topical administration of menthol leads
to an increase in serum glucagon levels, thus activating several downstream catabolic processes like
the browning of WAT and activation of energy expenditure markers in WAT and BAT [160].
Some studies also demonstrated the induction of the browning process through TRPM8 activation
on human WAT, highlighting the importance of the presence of TRPM8 in adipose tissue [161,162].
However, to date, no studies have been found that directly relate this species to miRNA and the
browning process. Nevertheless, an in vitro study showed that L-menthol administration at bioavailable
doses significantly increased browning/brite and the energy expenditure phenotype and enhanced
mitochondrial activity-related gene expression [163]. In addition, an in vivo experiment has found that
dietary menthol enhanced WAT browning and improved glucose metabolism in HFD-induced obesity
mice, which suggests that TRPM8 might be involved in WAT browning by increasing the expression
levels of genes related to thermogenesis and energy metabolism [164].
4.2.5. Chrysin
Chrysin (5,7-dihydroxyflavone) is a natural flavonoid found in honey, propolis, mushrooms,
and other plant species [165,166]. Also, it has been reported that chrysin exhibits an antioxidant
and anti-inflammatory effect, a protective effect against diabetes, and also possesses neuroprotective
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activity [165–167]. In fact, its role in the activation of thermogenesis or browning effect is less studied.
Choi et al. [168] reported that 3T3-L1 adipocytes treated with 50 µM of chrysin in the presence of
a 50 nM triiodothyronine and 1 µM rosiglitazone (a “browning cocktail”) from day six to eight of
differentiation presented increased expression of proteins/genes related to lipolysis and fatty acid
oxidation, and decreased the expression of proteins related to lipogenesis. Moreover, chrysin increased
the expression of brown fat markers in these cells via a mechanism involving AMPK and PGC-1α. It is
important to note that, like the curcumin, chrysin too has been related to the miRNA-34a.
4.2.6. Soy
Isoflavones are a subgroup of flavonoids present in soybeans and other legumes [169]. Genistein
is an isoflavone widely studied in different cells and animal models. Some of the biological properties
of genistein highlight its anti-obesity effect [170]. In this context, Lephart et al. [171] demonstrated
significantly upregulated Ucp-1 mRNA expression levels in BAT of Long-Evans rat supplemented with
soy isoflavone mixture. In a recent in vitro study, genistein programmed adipocytes to be converted
into beige adipocytes. In the first place, the treatment consisted of adding genistein at concentrations of
10, 50, or 100 µM during the differentiation period. Furthermore, the molecular mechanisms involved
could be a reduction in mRNA levels of genes related to lipogenesis and increased expression of
genes that regulate the development of brown adipocytes such as Cebpβ and Pgc-1α [172]. On the
other hand, a recent study evaluated the effect of genistein in an in vivo model in which mice were
fed an HFD supplemented with genistein (0.25 g/kg diet) for eight weeks. To point out, the results
showed less weight gain, sWAT weight, and free fatty acid levels in mice supplemented with genistein
compared to the HFD group. Regarding the mechanisms, the authors emphasize the correlation
between the differentially expressed genes in the hypothalamus and browning markers induced by
genistein supplementation [173].
Daidzein is another isoflavone whose effect on body weight and lipid metabolism has been
studied in WAT and BAT. In this context, rats were supplemented with daidzein (5 mg/kg and 50
mg/kg) for 10 weeks. The results showed expression changes in genes involved in adipogenesis and
fatty acid oxidation. Furthermore, daidzein treatment increased UCP-1 protein expression in BAT,
activating the thermogenesis [174]. Regarding miRNAs modulated by genistein, to date, there is no
specific evidence on miRNAs that regulate the browning process and BAT. Nevertheless, genistein was
associated with decreasing miR-155 and consequently improved inflammation in an in vitro model
with human umbilical vein endothelial cells (HUVECs) [175]. In addition, another study reported the
anticancer effects of genistein by modulating miR-155 in breast cancer cells [176]. However, additional
studies are needed to analyze the effect of genistein on miR-155 in relation to BAT.
4.2.7. Green Tea Polyphenols
Tea polyphenols have been reported to have many health benefits, such as antioxidant and
anti-inflammatory activities [177]. The predominant constituents of green tea, accounting for up to 35%
of the dry weight, are the polyphenols, which include flavonols, flavones, and flavan-3-ols commonly
known as catechins [178]; these are present also in fruits, such as apple, grapes and berries, beans,
cocoa and red wine [179]. In fact, catechins have received much attention due to their beneficial
effects on health [180]. The most abundant green tea catechin is epigallocatechin gallate (EGCG),
which accounts for about 50% to 70% of green tea catechins [82]. Mice fed 0.5% polyphenolic green
tea extracts rich in catechins and EGCG for eight weeks showed whitening of the BAT and induced
the browning process in the WAT [181]. Meanwhile, rats supplemented with green tea extract (155
mg/kg/day for eight weeks) showed higher expression of both Ucp-1 and Ppar-γ [182]. In essence,
the intake of oolong, red, and black tea has been found to reduce adiposity and foster browning of
mWAT in mice, and these effects were accompanied by increased AMPK phosphorylation [183]. In fact,
most studies have found greater activation of regulatory genes in the browning effect. A study on
mice evaluated the influence of a single oral administration of theaflavins on energy metabolism and
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found an increase in Ucp-1 and Pgc-1α mRNA levels in BAT. These results indicate that theaflavin
rich fraction significantly enhances systemic energy expenditure, as evidenced by an increase in the
expression of metabolic genes [184]. On the other hand, 3T3-L1 preadipocyte cell showed significantly
reduced intracellular lipid accumulation by targeting miR-27a and miR-27b, as well as Ppar-γ [185].
In recent years, an increasing number of clinical trials have confirmed the beneficial effects of green
tea on obesity; however, the optimal dose has not yet been established. However, a clinical trial has
shown that the intake of catechin (615 mg) and caffeine (77 mg) 2 times/day for five weeks increases
the cold-induced thermogenesis effect [186]. Overall, most of the studies aimed to assess the impact of
green tea catechins on fat oxidation rather than thermogenesis; therefore, more studies are necessary to
evaluate their involvement in the browning process in humans.
4.3. PUFA’s
4.3.1. Conjugated Linoleic Acid
Conjugated linoleic acids (CLAs) are molecules mostly found in dairy products and ruminant
meats [187]. CLA is a group of PUFA derived from linoleic acid (LA, C18:2 n-6), with a conjugated
double bond in different cis- and trans-arrangements [188]. Additionally, twenty-eight isomers of
CLA have been identified, with the predominant isomers being cis-9, trans-11-CLA (c9, t11-CLA),
which represents up to 90% of total CLA in food, and trans-10, cis-12-CLA (t10,c12-CLA), present in a
smaller quantity [189]. Some studies have suggested that CLA leads to weight loss by reducing the
size and altering the evolution of adipocytes [190]. In fact, proposed anti-obesity mechanisms of 10, 12
CLA isomer include decreased lipogenesis and increased lipolysis [191]. Moreover, Cidea has been
associated with thermoregulation [192], lipid droplet dynamics, and lipid metabolism [193]. A study in
human adipocytes treated with CLA found an upregulation of Cidea and Ucp-1 genes, setting the role
of Cidea in the transcriptional regulation of thermogenesis [194]. Also, it has been described that CLA
induces the browning of WAT, increasing Ucp-1 and Cidea gene expression in both and iWAT, with
higher Ucp-1 mRNA and protein detected in iWAT from 10,12 CLA-supplemented mice [195]. Male
mice fed an HFD diet for five weeks and then switched to an LFD with or without 0.1% 10,12 CLA
decreased WAT weight and increased mRNA levels of genes related to thermogenesis and fatty acid
oxidation in eWAT and iWAT, including Ucp-1 and Ppar-α [196]. Nevertheless, in vitro studies indicate
that direct treatment of pre-adipocytes with trans-10, cis-12 CLA increased markers of inflammation
and suppressed markers of beiging or browning. A study in human adipocytes showed that 30–50
µM trans-10, cis-12 CLA consistently decreased the mRNA, protein, and activity levels of PPARγ, an
adipogenic transcription factor that induces Ucp-1 expression [197]. Furthermore, in brown adipocytes
isolated from hamsters, mRNA levels of Ucp-1 were increased 260% by 71.4 µM cis-9, trans-11 CLA,
but were suppressed 80% by 71.4 µM trans-10, cis-12 CLA compared with the controls [198]. Most
studies have been developed in in vivo models indicating positive regulation of browning markers;
however, in vitro experiments indicate that the effect of 10,12 CLA is still unclear. Regarding miRNA,
CLA mediates its pro-resolving effects in part via regulation of the proinflammatory miR-155, which
has been associated with the WAT browning effect [199].
4.3.2. Eicosapentaenoic Acid
Fish oil, rich in omega-3 (n-3) PUFAs such as eicosapentaenoic acid (C20:5n-3, EPA), is
anti-inflammatory primarily by reducing the production of proinflammatory cytokines [200].
Furthermore, it has been suggested that EPA is able to enhance energy dissipation in subcutaneous
adipose tissue to stimulate oxidative metabolism and reduces fatty acid release by facilitating fatty acid
storage in mice [201]. In addition, it has been shown that EPA promoting mitochondrial biogenesis
and beige-like markers in human subcutaneous adipocytes from overweight subjects [202]. For this
reason, there is evidence that EPA may induce adipocytes to acquire a beige phenotype and may
activate brown thermogenesis. In addition, fish oil increased thermogenic markers in the BAT, such as
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β3-AR and Ucp-1 [203,204]. C57BL/6 male mice fed with EPA for five weeks improved the expression
of genes related to the browning of WAT, and BAT thermogenic markers such as Ppar-α, Ppar-γ, and
fibronectin and fibronectin type III domain-containing 5 (FNDC5) [203]. Zhao et al. [201] reported
that EPA significantly increased the expression of thermogenic genes like Ucp1-3, Cidea, and Vegfα.
In addition, carnitine palmitoyltransferase 1B (Cpt1b) mediates the transport of fatty acids into the
mitochondrial matrix for β-oxidation. It has been reported that EPA promotes brite adipogenesis and
improves the parameters of mitochondrial function, such as increased expression of Cpt1b [205]. On
the other hand, miRNAs play critical functions in BAT differentiation and maintenance. The deletion of
adipose-specific dicer promotes white-like phenotypes of brown precursor cells [206]. In this context,
Kim et al. [76] confirmed the association between miR-30b/378 and brown thermogenesis in C57BL/6
mice fed with fish oil.
4.3.3. Docosahexaenoic Acid
Docosahexaenoic acid (DHA) is a long-chain, highly unsaturated omega-3 (n-3) fatty acid. It
has a structure that gives it unique physical and functional properties, as well as 22 carbons in its
acyl chain, which includes six double bonds. DHA is found in fairly high amounts in seafood and
products derived from seafood. Examples of fatty fish are mackerel, salmon, trout, herring, tuna,
and sardines [207]. In fact, DHA is of particular interest, given their potential effects on adipose
tissues and metabolism [208]. Also, it has shown a better anti-inflammatory effect than EPA in adipose
tissue, which may be related to a more significant role of DHA in promoting Ucp-1 expression [209].
Additionally, recent studies showed that BAT activation or WAT browning of WAT by n-3 PUFAs were
independent of Ucp-1 [210]. It was shown that refeeding rats a diet enriched in PUFAs, but not in
saturated fatty acids, following two weeks of food restriction increased BAT mass and expression of
Ucp-1 [211]. Nonetheless, the thermogenic stimuli via the intervention with DHA and their ability to
induce Ucp-1 in WAT are still controversial [212].
4.4. Carotenoids
4.4.1. β-Carotene
Carotenoids are a diverse group of compounds responsible for most of the yellow, orange, and
red colors in fruits and vegetables [213]. Among the six most abundant carotenoids in plasma,
α-carotene, β-cryptoxanthin, lutein, zeaxanthin, lycopene, and β-carotene [214]. Carotenoids are
notably stored in adipose tissue [215]. What is more, carotenoids and carotenoid conversion products
impact gene expression and cell function through multiple mechanisms. The most important carotenoid
is pro-vitamin A β-carotene, which is metabolized by various enzymes to generate several cleavage
products, including retinoic acid (RA) [216]. The effects of carotenoids and retinoids on adipose tissue
mostly rely on their ability to bind to specific nuclear receptors, namely RA receptors (RARs) and
retinoid X receptors (RXRs), in order to modulate gene expression in the adipocyte [217]. However,
it has been suggested that carotene within the BAT could be metabolized to a significant degree
to retinoic acid and, thus, become a Ucp-1 activator [218]. Studies have also reported the effect of
carotenoid-related compounds in increasing energy expenditure and thermogenesis in both WAT and
BAT; nonetheless, the interaction with miRNA has not been analyzed. The participation of β-carotene
in the modulation of Ucp-1 expression was established by in vitro studies [219]. Furthermore, the
treatment with RA in murine BAT cells induces an overexpression of thermogenic and catabolic
proteins [220].
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4.4.2. Fucoxanthin
Fucoxanthin is a natural pigment that can be extracted from brown seaweeds and is rich in
xanthophylls (a subset of carotenoids) [221]. Dietary fucoxanthin is mostly absorbed as fucoxanthinol,
a hydrolyzed metabolite in the small intestine, and enters systemic circulation through lymph [222].
Although, it is demonstrated that fucoxanthin is involved in a variety of physiological processes in
the body and have many beneficial properties, including the antioxidant and anti-inflammatory and
neuroprotective effect [223]. Indeed, fucoxanthin an anti-obesity effect in both in vitro and in vivo
in mice and human models [224]. In 3T3-L1 adipocytes, fucoxanthin reduced lipid accumulation
accompanied by a decrease in Ppar-γ expression [225]. However, the intake of an HFD supplemented
with 0.2% fucoxanthin in C57BL/6 mice increased Ucp-1 expression in both WAT and BAT [221,226].
Maeda et al. [227] indicated that fucoxanthin upregulates the expression of Ucp-1 in WAT, which may
contribute to reducing WAT weight. Overall, obese mice fed with fucoxanthin showed a decrease
in WAT weight as well as a significant upregulation in the expression of UCP-1 mRNA and protein
in WAT, resulting in an increase in energy expenditure in the form of heat and fatty acid oxidation
in WAT [227]. These studies suggest that fucoxanthin may have promising anti-obesity effects and
deserve more research focus especially related to miRNAs and primarily in human subjects, as the
results are still confusing. For example, Rebello et al. [228] did not find changes in the expression
of genes related to WAT browning, fat oxidation, and glucose transport in vitro in primary human
adipocytes treated with fucoxanthin.
4.5. Citrus Fruits
Citrus fruits are a source of numerous phenolic compounds, pectins, and vitamins such as A, C,
and E [229,230]. In recent years it has been shown that a diet rich in phenolic compounds can improve
health and reduce the incidence of different diseases [231]. Some of the flavonoids found in citrus
sources, such as orange, grapefruit, and lemon, are naringenin and hesperetin from the flavanones
group, as well as other subtypes of flavonols, such as kaempferol, and also certain hydroxycinnamic
acids [232]. Regarding obesity, one study in mice (1%) for 21 days found an increase in fatty acid
oxidation in hepatocytes [233]. On the other hand, another study showed anti-inflammatory activity of
naringenin in in vitro macrophages [234]. In addition, a study conducted on a murine cell line treated
with Citrus aurantium extract (10–50 µg/mL) found inhibition of adipocyte differentiation, preventing
lipid accumulation [235]. Although there are many studies that have focused on the anti-obesity effect
of the phenolic compounds from citrus fruits, the effect on BAT activation and the WAT browning
process has not been fully elucidated. Furthermore, a recent study demonstrated a thermogenic
effect in brown adipocytes after treatment with bitter orange possible due to AMPK activation [236].
In addition, an in vivo study evaluated the effect of immature citrus fruits (1%) in HFD fed mice for 11
weeks and found an increased expression of Ucp-1 in iWAT, thus suggesting that weight loss might be
attributed to the browning process in WAT [237]. In this context, Nishikawa et al. [238] analyzed the
effect of α-monoglucosyl hesperidin in mice, as a simple glycosidic flavanone, and found a significant
decrease in body fat, which may be due to the activation of the browning process in iWAT. Also, another
recent study evaluated the effects of naringenin on energy expenditure in human WAT (hWAT). In this
context, when adipocytes were treated with naringenin for seven days, the browning process was
activated through the induction of Ucp-1 as a key marker in the thermogenesis pathway [228]. Overall,
some effects of citrus flavonoids on thermogenesis have been identified, but naringenin-mediated
modulation of miRNAs has not been reported to date. Figure 3 displays some of the most studied food
compounds, and the main candidates target genes that promote WAT browning.
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Figure 3. Food compounds and activated genes involved in WAT browning. Fgf21, Fibroblast growth
factor 21; Tmem26, Transmembrane protein 26; Pparγ, Peroxisome proliferator-activated receptor
gamma; Pparα, Peroxisome proliferator-activated receptor α; Cidea, Cell death inducing DFFA like
effector A; Prmd16, PR-domain containing 16; Pgc-1α, Peroxisome proliferator-activated γ receptor
co-activator 1 alpha; Ucp-1, Uncoupling protein-1.
5. Conclusions
In summary, the detection of BAT in adult humans has raised the expectations for the development
of novel anti-obesity treatments that can regulate brown or beige fat development. Recently, inducible
brown adipocytes in WAT depots, called beige or brite cells, have gained more interest due to their
increased capability of energy expenditure and their positive effect on diet-induced obesity. For
instance, we focused on miRNAs and food compounds like key regulators of brown adipogenesis and
the commitment of beige adipocytes to a brown phenotype during the “browning” process. Current
knowledge deriving from clinical trials, cell culture, and animal models suggests that miRNAs can be
implicated in the regulation of the critical genes involved in the differentiation and function of WAT
and BAT, highlighting miRNAs as therapeutic targets for obesity. However, the dietary components
discussed above have been shown to share common molecular targets involved in the induction of
browning. In the long run, these findings need to be validated in more clinical trials by further large
studies with a relatively long-term period of follow-up and taking into consideration factors such as
ethnicity, genetics, and lifestyles.
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Abbreviations
AMPK AMP-activated protein kinase
AMPKα1 5-AMP-activated protein kinase catalytic subunit alpha-1
BAT Brown adipose tissue
BMP7 Bone morphogenetic protein 7
BW Body weight
C/EBPα CCAAT/enhancer binding protein alpha
Cd137 4-1BB
Cd40 CD40 molecule
CIDEA Cell death inducing DFFA like effector A
CITED1 Cpb/P300 interacting transactivator with Glu/Asp rich carboxy-terminal
CLA Conjugated linoleic acid
Cox8 Cytochrome c oxidase subunit 8
CPTB1β Carnitine palmitoyltransferase I
DHA Docosahexanoic acid
Dio2 Iodothyronine deiodinase 2
EGCG Epigallocatechin gallate
Elovl3 Elongation of very long-chain fatty acid 3
EPA Eicosapentanoic acid
ERK Extracellular signal-regulated kinases
eWAT Epididymal WAT
Fgf32 Fibroblast growth factor 23
FNDC5 Fibronectin type III domain-containing protein 5
Foxc2 Forkhead box C2
HFD High-fat diet
HUVECs Human umbilical vein endothelial cells
hWAT Human white adipose tissue
iWAT Inguinal WAT
LA Linoleic acid
LFD Low-fat diet
LPS Lipopolysaccharides
MAPK Mitogen-activated protein kinase
miRNAs MicroRNAs
mWAT Mesenteric WAT
Myf5 Myogenic factor 5
NAFLD Nonalcoholic fatty liver disease
OPE Onion peel extracti
Pgc-1α Peroxisome proliferator-activated γ receptor co-activator 1 alpha
Ppargc1b PPARG coactivator 1 beta
Pparα Peroxisome proliferator-activated receptor α
Pparγ Peroxisome proliferator-activated receptor gamma
Pparδ Peroxisome proliferator-activated receptor delta
Prmd16 PR-domain containing 16
PUFA Polyunsaturated fatty acids
RA Retinoic acid
RAR Retinoic acid receptor
RNA Ribonucleic acid
rWAT Retroperitoneal WAT
RXR Retinoid X receptor
Sirt-1 Sirtuin 1
sWAT Subcutaneous WAT
Tbx1 T-box 1
tCA Trans-cinnamic acid
TG Triglycerides
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Tmem26 Transmembrane protein 26
TRPM8 Transient receptor potential cation channel subfamily M (melastatin) member 8
TRPV1 Transient receptor potential vanilloid subfamily 1
UCP-1 Uncoupling protein-1
UCP-2 Uncoupling protein-2
VEGFα Vascular endothelial growth factor alpha
WAT White adipose tissue
β3-AR Beta3 adrenergic receptor
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